CCM
HCWB icon

Connective Capital Management’s HCW Biologics HCWB Stock Holding History

Connective Capital Management’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Buy
+3,338
New +$18.9K 0.01% 66

Other funds holding HCWB

VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Connective Capital Management's HCWB Position: Q2 2026 in Review

Connective Capital Management opened a new position in HCW Biologics (HCWB) in Q2 2026: 3,338 shares worth $16.7K. The stake represents 0.01% of the portfolio and ranks #66 among its holdings.

7 funds tracked by Wall St. Rank hold HCWB as of Q2 2026.

  • Connective Capital Management held 3,338 shares of HCW Biologics worth $16.7K as of Q2 2026.
  • HCW Biologics was a new Connective Capital Management position in Q2 2026.
  • HCW Biologics made up 0.01% of Connective Capital Management's portfolio in Q2 2026, its #66 holding.
  • 7 funds tracked by Wall St. Rank held HCW Biologics as of Q2 2026.

Based on Connective Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.